| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 56.3% | 9/16 |
| Female | 43.8% | 7/16 |
| Indifferent | 0% | 0/16 |
| Unknown | 0% | 0/16 |
| General | ||
| Birth Length | 0% | 0/8 |
| 25% | 2/8 | |
| 12.5% | 1/8 | |
| 40% | 4/10 | |
| 25% | 2/8 | |
| 92.9% | 13/14 | |
| 77.8% | 7/9 | |
| 87.5% | 14/16 | |
| 93.3% | 14/15 | |
| 73.3% | 11/15 | |
| Neurology | ||
| 100% | 16/16 | |
| 81.3% | 13/16 | |
| 50% | 8/16 | |
| Facial abnormalities | ||
| 31.3% | 5/16 | |
| 43.8% | 7/16 | |
| 37.5% | 6/16 | |
| 31.3% | 5/16 | |
| Visual and hearing impairments | ||
| 6.3% | 1/16 | |
| 18.8% | 3/16 | |
| Heart | ||
| 12.5% | 2/16 | |
| Gastrointestinal | ||
| 25% | 4/16 | |
| Urogenital | ||
| 6.3% | 1/16 | |
| Skeleton | ||
| 68.8% | 11/16 | |
| Skin / Hair / Nails | ||
| 25% | 4/16 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/16 |
| 6.3% | 1/16 | |
| Immune | 0% | 0/16 |
| Neoplasia | ||
| Neoplasia | 0% | 0/16 |
| Inheritance | ||
| 87.5% | 7/8 | |
DYRK1A